ArticleJournal of diabetes and metabolic disorders2025
The linear association between high-density lipoprotein cholesterol and diabetic retinopathy : a cross-sectional study in diabetic patients.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and a leading cause of visual impairment. While dyslipidemia has been implicated in DR pathogenesis, the relationship between high-density lipoprotein cholesterol (HDL-C) and DR remains controversial. This study aimed to investigate the association between HDL-C levels and DR prevalence in diabetic patients type 2 diabetes mellitus (T2DM). Methods: This study is the second analysis based on a cross-sectional studv. A total of 2001 (858 men and 1143 women) diabetic patients who visited the diabetic clinic in the Internal Medicine out-patient departments of two hospitals in southern Taiwan between April 2002 and November 2004. Demographic and clinical data were collected, and serum HDL-C levels were measured. The association between HDL-C and DR was analyzed using multivariate logistic regression, accounting for potential confounders. Additionally, we explored the potential correlation between HDL-C and DR through a smooth curve fitting approach, utilizing a generalized additive model (GAM). and a generalized additive model (GAM). Results: Among the 2001 participants, 701 (35.0%) were diagnosed with DR. Our findings demonstrated a significant inverse linear relationship between HDL-C levels and the presence of DR. Higher HDL-C was inversely associated with diabetic retinopathy (DR). In continuous analyses, each 10 mg/dL increase in HDL-C corresponded to lower odds of DR across all models, including Model 3 (OR 0.92; 95% CI 0.84-0.99; Conclusions: This study provides evidence of a linear association that elevated HDL-C levels are associated with decreased odds of DR in diabetic patients. Future research should further focus on elucidating the mechanisms underlying this association and its implications for therapeutic strategies. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01728-z.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.